science short

Probiotic yeast shows IBS benefits: 63% v 47% (placebo)

By Shane STARLING contact

- Last updated on GMT

Probiotic yeast shows IBS benefits: 63% v 47% (placebo)

Related tags: Irritable bowel syndrome

A proprietary probiotic yeast reduced abdominal discomfort among Irritable Bowel Syndrome (IBS) sufferers, a study has found.

200 IBS-inflicted individuals were split into two groups in the randomised, double blind, placebo-controlled study. After four weeks, 63% of those taking the probiotic yeast saccharomyces cerevisiae​ (CNCM I-3856) showed improvement compared to 47% in the placebo group.

The ingredient is part of nutrient specialist Lesaffre’s suite going under the commercial name Lynside Pro GI+. The French firm funded the study, published in Digestive and Liver Disease and conducted at the University of Lille in France.

Lesaffre said it is the first probiotic yeast to show IBS benefits, or even target the condition.

Those in the study group each consumed 500 mg of the probiotic.

Lead researcher and IBS specialist professor Pierre Desreumaux said the results were encouraging. 

“The consumption of this probiotic yeast was well tolerated and the analgesic effect observed was not mitigated by any adverse side effects,”​ he said, adding, “even long term treatments could be contemplated considering the absence of side effects.”

The strain is registered with the French National Collection of Microorganism Cultures as CNCM I­3856.

Source:

Digestive and Liver Disease

Volume 47, Issue 2​, February 2015, Pages 119–124

‘A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome’

Authors: Pierre Desreumaux et al

Related news

Show more

Related products

show more

HRB are ideal probiotics for human health

HRB are ideal probiotics for human health

Morinaga Milk Industry Co., Ltd. | 19-Sep-2019 | Technical / White Paper

Evidence is accumulated that the physiological benefits of probiotics bifidobacteria are not only strain-specific but also dependent on their residential...

Fermented Soy for Natural Digestive Support

Fermented Soy for Natural Digestive Support

Lallemand Bio-Ingredients | 22-Apr-2019 | Technical / White Paper

Lallemand is running a new clinical trial for Gastro-AD® in spring 2019. Gastro-AD® is a clinically studied food supplement based on non-GMO soy fermented...

BIONAP: BIODIVERSITY AND SCIENTIFIC APPROACH

BIONAP: BIODIVERSITY AND SCIENTIFIC APPROACH

BIONAP Srl | 18-Apr-2019 | Interview

At VITAFOODS 2019, BIONAP will present a wide range of sustainable and innovative solutions for: BRAIN HEALTH , SPORT & NUTRITION, SKIN PROTECTION,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars